Commercial Litigation Finance: How Big is This Thing?

Commercial Litigation Finance: How Big is This Thing?

The following article is part of an ongoing column titled ‘Investor Insights.’  Brought to you by Ed Truant, founder and content manager of Slingshot Capital, ‘Investor Insights’ will provide thoughtful and engaging perspectives on all aspects of investing in litigation finance.  Executive Summary
MarketAustralia (AUS$)UK (£)USA (US$)
Implied Commitment CapacityAUS $1B£2BUS $10B
Implied Annual commitments1AUS $333MM£667MMUS $3.3B
The chart above summarizes the results of quantifying the size of the most mature markets for litigation finance.  If you were to attempt to perform the same analysis three years ago, I suspect you would find that the industry was less than half its current size.  Accordingly, it is a dynamic and growing market that should be on most investors’ radar screens if you are interested in non-correlated exposures. Investor Insights
  • Growing, dynamic market
  • Diversification is critical to responsible investing; “tail risk” can be significant
  • Relatively few managers with long track records
  • New investors should focus on the small subset of experienced fund managers
Approach and Limitation of Sizing I am often asked about the size of the commercial litigation finance market by individual and institutional investors alike, whether relative to the US market or other large global markets. I often hesitate to answer the question as the answer is dependent on an element of transparency not currently inherent in the industry itself.  Nevertheless, I think it is important for all stakeholders to understand the size of an industry, so investors can determine whether it has the scale and growth attributes necessary to justify a long-term approach to investing in the sector. However, before I describe the approaches taken, I think it is important to recognize the limitations of attempting to size the industry, as past estimates have varied wildly. Limitation #1: Dedicated Funds vs. Opaque Capital Pools vs. Non-Organized Capital Pools While there are many dedicated litigation funders (“Funders”) servicing the global marketplace, both private and publicly-traded, they only represent a portion of the available financing for the industry (especially in the US). Even the Funders that service the market are relatively private about the amount of capital they have available and the amount of capital they deploy annually (not to mention committed capital vs. drawn capital).  On the odd occasion, you will have a funder trumpet their latest close size, but it is often just a headline number and you are left wondering exactly what it means as it could be inclusive of co-invest capacity, side cars, discretionary separately managed accounts, etc. Then there are the Opaque Capital Pools.  These are the hedge funds, the multi-strategy funds with a sliver of their fund dedicated to litigation finance, merchant banks, credit funds, etc.  Even PIMCO, the world’s largest bond fund, has allocated capital to one of the UK funders (a tiny allocation for PIMCO, but perhaps the ‘thin edge of the wedge,’ if they achieve success).  The problem from a data perspective is that many of these funding sources don’t disclose how much of their capital has been allocated to litigation finance, as they don’t necessarily want the world, or their competitors, to know where they are investing. Finally, there are a host of other financiers in the marketplace, which I will refer to as Disorganized Capital Pools.  These are the lawyers, law firms, High Net Worth (HNW) and Ultra HNW (UHNW) individual investors, family offices and the like that have decided they want exposure to single case risks or portfolios thereof.  Investors who have not dedicated a lot of time and attention to the asset class are probably best served by investing in a series of funds, as opposed to going direct with one manager or a series of individual cases. Often times, the second and third categories are what I call flexible pools of capital, meaning that if they achieve success in investing they will allocate more capital, and if they don’t have a positive experience they will retreat and ‘run-off’ their remaining investments, and “chalk that one up to experience”.   The Opaque Capital Pools and Disorganized Capital Pools are what I refer to as “Non-Fund Investors”.  Accordingly, due to the flexibility and private nature of the Opaque and Disorganized Capital Pools, it is difficult to determine the exact amount of capital they represent at any given point in time. Limitation #2: Financing Fees vs. Financing Out of Pocket There is a distinction in the industry between financing legal fees (which is not always possible in all jurisdictions) and financing out-of-pocket expenses (court costs, discovery costs, expert reports, etc.).  There is also a third bucket where financiers will provide “working capital” as part of their litigation finance commitment. Funds which provide working capital are grounded in a belief by the Funder that the piece of litigation has value, and if the value exceeds the various costs necessary to pursue the case, then they are comfortable providing any excess capital to the business for working capital purposes.  The other aspect to working capital is that the litigation funder does not want to find itself in the middle of litigation with an insolvent enterprise where the management team is no longer focused on the litigation prize, and so they argue it is in their best interest to keep the company solvent while the litigation is being pursued.  Arguably, working capital loans belong in the world of specialty finance, not litigation finance, but in this case the underlying security is the outcome of the litigation. The reason I draw the first distinction is because it could be argued that a large segment of litigation finance is already being provided through contingent fee arrangements, which have been in existence for decades in the US, but have been the sole purview of lawyers.  Should these contingent fees count towards industry sizing?  I think a logical argument can be made that they should be included, as these are funds that could or would otherwise be provided by a third-party litigation funder, but then again, they will never be funded by Funders. Some people believe that law firms are taking the best cases for themselves and the litigation funding industry is fighting for the cast-offs (termed ‘adverse selection risk’).  I don’t necessarily subscribe to this theory, as the high success rates in the Litigation Finance industry support the notion that good cases are being undertaken by third party funders. Interestingly, one of the world’s largest law firms, Kirkland & Ellis, recently announced that they are going to double down on their contingent fee arrangements through the establishment of a plaintiff side litigation group, which was previously the sole purview of scrappy plaintiff side lawyers (many of whom have achieved tremendous financial success in doing so). Perhaps the grass really is greener… For the purpose of this article, I have assumed that contingent fees are not included in the industry sizing exercise. Limitation #3: It’s Getting Global A few years ago, the various funders were entrenched in their local jurisdictions and happy to toil away in their own back yards. Then something interesting happened.  It got global, fast!  Over the last 3-5 years, the industry saw litigation funders move outside of their home base, and do so in a significant way.  UK funders moved into the US, Australian funders moved into the US and UK, UK funders moved into Australia, and more recently, some funders figured my host country, Canada, was also an interesting opportunity.  Is this a reflection of their local markets being saturated, or is this a global ‘land grab’? I point this out because when you analyze pools of capital by litigation funders, you cannot solely look at where that funder is domiciled and conclude their capital is solely dedicated to their home country.  Some funders, like IMF Bentham, have set up dedicated pools to service the US and other pools to service Rest of World (i.e. ex-US).  Other funders do not have dedicated pools, but look for the best risk-adjusted opportunities around the globe, or in specific markets in which they are comfortable investing (typically other English common law or common law derived markets, but not necessarily so).  I say this because the available data forces one to look at global litigation funding sizing, as it is difficult to know where the funder will deploy its capital.  This doesn’t even consider foreign exchange rate fluctuations and their effect on industry sizing – the Brexit impact on the GBP would have had a significant impact on the USD equivalent alone. Limitation #4: Cultural Differences and Punitive Damages There is no arguing that the US is a much more permissive culture in terms of utilizing litigation to settle differences – ‘nothin’ like a good gun fight to settle a dispute’, one might say.  This means that while the size of the litigation industry is much larger, one could argue that you have to parse out the less meritorious claims to find the jewels that litigation finance would support – their money is not frivolous, hence the cases they fund are also not frivolous. Accordingly, when you look at the size of the entire industry, you must assign a lower litigation funding applicability rate in the US because of the aggressive nature of the claim environment (i.e. while the US legal market is much larger because the culture is more permissive, there are a smaller percentage of claims that attract litigation finance). The second and more important issue, is the relative extent of punitive damages in the American civil justice system vs other civil justice systems.  There is no doubt – and it has been well documented through empirical evidence – that awards are larger in the US.  Accordingly, this would suggest that comparing data from other jurisdictions and applying that to try and size the US market, or any other market for that matter, is somewhat limiting. In addition, each market has its own nuances and peculiarities, and so it is very difficult to compare different jurisdictions and draw solid conclusions.  All of the aforementioned would suggest the industry is difficult to size with any degree of accuracy.  I think there is some truth to that supposition. Limitation #5 – What is included in “Commercial”? While the commercial litigation finance market is generally defined to include financing of litigation involving two corporate entities, the funders involved in the space have expanded the definition to include, amongst other things, Investor-State, product class action and insolvency cases where there is typically not another commercial entity on the other side of the dispute, but rather a sovereign, a set of consumers or an individual (director or shareholder), respectively.  Accordingly, the commercial litigation finance funders have expanded the definition of what is included in the market by including large, complex cases involving non-commercial entities.  Nevertheless, these cases are typically financed by commercial litigation finance funders and should be captured in the size estimates. So, with all of the limitations above, I have tried to approach industry sizing using a pair of different approaches: micro and macro. Macro Perspective:  When looking at it from a macro perspective, I like to focus on one of the more mature markets for litigation finance and draw inferences – that market being Australia. Australia is a common law market; it has been utilizing litigation finance for close to two decades, and therefore is one of the more mature markets, which suggests market penetration for Litigation Finance is relatively high.  The one limitation of using Australia as a benchmark is that the jurisdiction generally does not allow contingent fees, so arguably, litigation finance levels are higher because lawyers are not able to put their fees at risk, hence their fees are financed by Funders.  I also believe Australia has fewer Non-Funder investors than the United States, and so we can likely draw better conclusions about the size of their market by looking at the active funders there. The following chart attempts to put the relative markets into perspective.
CountryContingent FeesAdverse CostsLitigation CultureLegal MarketFunding Type
USYesNoPermissive$437B USLegal fees, working capital & disbursements
UKYesYesModerate£29B GBPLegal fees & disbursements
AustraliaNoYesModerate$21B AUDLegal Fees, disbursements & indemnities
So, if one considers the Dedicated Funds in Australia, and tries to estimate the amount of capital they have dedicated to the local industry and compare that to the overall size of the litigation market (a number that is fairly well tracked), we can see that the Australian market is approximately AUS$200-300MM in annual commitments, and has commitment capacity of about 2-3 times that, or $500-750MM (using the mid-point).  This would suggest that litigation finance – in terms of annual commitments – represents about 1 to 1.5% of their $21B legal market (where the “legal market” is the market for all legal services, not just those dedicated to litigation). Applying the same methodology to the UK market, and adjusting for the fact that contingent fees are more prevalent in the UK, one could argue that the UK market, being younger than the Australian market, should be less penetrated, with less capital being required due to contingent fees.  Perhaps the litigation finance market is closer to 1% of the legal market, or approximately £290MM and commitment capacity of 2-3 times that amount of £600-900MM. Extending this logic to the US market, and allowing for a strong punitive damage system, strong contingent fee usage and a low relative penetration rate, we can surmise that the market is similarly close to 1% of the size of its legal market, or $4B in annual commitments with commitment capacity of 2-3 times that or $8-12B.
MarketAustralia (AUS$)UK (£)USA (US$)
Commitment CapacityAUS $500-750MM£600-900MMUS $8-12B
Annual CommitmentsAUS $ 2-300MM£250-350MMUS $3-4B
Micro Perspective: The other approach to sizing the market is to build up the annual commitments and the commitment capacity on an investor-by-investor basis.  Westfleet Advisors has recently published a “Buyer’s Guide” to estimate the size of the US market using this approach, and their results seem to correlate with the approach I have used below.  The difference in results between our two approaches results from the size of the non-fund sources of capital, and my approach is admittedly a best guess estimate.  Nevertheless, I have used the following assumptions to try and triangulate the market sizes.  I took my knowledge of the various funders’ commitment capacity in each of the jurisdictions to determine the total commitment capacity of the market, and then I interpolated the size of the total market by estimating what percent of funding is represented by these Dedicated Funds.
MarketAustralia (AUS$)UK (£)USA (US$)
Fund Commitment CapacityAUS $1B£1.6BUS $5B
% of Market represented by Funders100%80%50%
Implied Commitment CapacityAUS $1B£2BUS $ 10B
Implied Annual commitments1AUS $333MM£667MMUS $3.3B
1 Annual commitments determined by dividing the Commitment Capacity by 3 (typical fund investment period, assuming extensions)
Conclusion The two approaches seem to triangulate fairly well, and are buttressed by the micro analysis performed by WestFleet in the US market.  Accordingly, I think the two approaches provide a high-level view of the amount of capital available and annual commitments for the various jurisdictions.  While I would not rely on the exact figures, I believe the numbers are directionally correct, and provide investors with an order of magnitude assessment of the current market as to whether this market provides sufficient scale to justify a long-term exposure to the asset class, or whether investors should consider it a more opportunistic investment within one of their niche strategies or pools of capital. While the industry is presently not sizable enough to attract many large pension plans and sovereign wealth funds that typically invest no less than $100’s of million at a time, it is quickly achieving a level of scale that has become attractive to some larger investors. By example, a large sovereign wealth fund has made a US$667MM commitment to Burford’s 2019 Private Partnership through a separately managed account.  The remaining external capital, $300 million, was provided by a series of small and medium-sized investors rumoured to include family offices, foundations, endowments and the like.  Whereas this scale of investor would not have invested in the asset class even three years ago, it appears the more aggressive of these investors have decided this is an asset class that merits serious consideration and investment, and I expect more to follow. Investor Insight: For investors interested in investing in one of the truly non-correlated asset classes, they would be best to spend the time to analyze the various managers in the sector, of which there are relatively few on a global basis that I would consider “institutional” in nature.  They would also be well served to focus on those few managers with  a track record that includes fully realized funds, of which there are even fewer, or be prepared to spend the time and resources to assess the unrealized portion of those managers’ portfolios as ‘tail risk’ in this industry can be significant depending on the concentration of the portfolio.  As always, diversification is a key success factor to investing in this asset class as the idiosyncratic risk of cases and the binary nature of trial/arbitral awards make it particularly well suited for the application of portfolio theory. Edward Truant is the founder of Slingshot Capital Inc. and an investor in the consumer and commercial litigation finance industry.
Secure Your Funding Sidebar

Commercial

View All

Omni Bridgeway Posts Strong FY25 After ‘Transformational’ Year

By John Freund |

Omni Bridgeway has reported a step-change year, pairing robust investment performance with a balance sheet reset that positions the platform for its next growth phase. The ASX-listed funder highlighted headline income of $651.3 million, a $3.6 billion portfolio (up 29% year over year), and A$5.2 billion in assets under management. Returns were anchored by a 2.5x MOIC across 60 full and partial completions, while operating discipline showed through with a 6.2% reduction in cash opex. Management framed FY25 as both a consolidation of strategy and a proof point for the firm’s fair value marks.

An article in PR Newswire notes the year also brought 52 new investments totaling A$517 million in commitments and A$525.9 million added to fair value. Crucially, Omni executed its Fund 9 transaction with Ares—fully deleveraging and “significantly derisking” the balance sheet—while also validating its model with third-party institutional capital. CEO Raymond van Hulst called FY25 “a positive year with excellent investment returns and a transformative transaction,” adding that the platform is well placed for continued growth.

For a sector navigating evolving regulation and disclosure debates, the numbers matter—but so does capital formation. Omni’s ability to recycle capital, expand AUM and originate across jurisdictions reinforces the durability of legal assets as an alternative class.

Apex Litigation Finance Appoints Gabriel Olearnik as Head of Legal

By John Freund |

Apex Litigation Finance has strengthened its leadership team with the appointment of Gabriel Olearnik, a highly experienced litigation funding professional with a global track record in high-value dispute resolution and complex commercial matters.

Over the past five years, Gabriel has originated and reviewed more than 451 litigation funding cases worldwide with an aggregate value exceeding $116 billion, closing deals worth over $700 million. His recent work includes the successful settlement of a high-profile BIT matter as well as executive employment claims in the UK.

Gabriel’s career spans senior roles in UK, US and European litigation funders, where he was instrumental in structuring high-value transactions, securing strategic court orders and conducting multi-jurisdictional investigations. In 2023, he closed a £268 million litigation funding deal in just three weeks, underscoring his ability to deliver results under tight timelines.

Recognised by Lexology as one of only 66 lawyers worldwide to receive the Thought Leaders in Third Party Funding accolade, Gabriel has been involved in matters that have attracted daily media coverage and required innovative dispute strategies. His experience extends to training legal teams, advising on politically sensitive disputes, and executing complex enforcement actions.

“Gabriel brings exceptional global experience, deep sector knowledge, and a proven ability to deliver in high-stakes environments,” said Maurice Power, CEO of Apex Litigation Finance. “His appointment further enhances Apex’s market position and it’s ability to originate, evaluate and fund complex commercial claims for our clients.”

“I am delighted to join Maurice and the team at Apex,” said Gabriel. “Apex’s strong financial backing and their speed of execution make this a natural alignment. I look forward to building on the strong foundation set out by my predecessor, Stephen Allinson, and contributing to the future success of the business.”

Gabriel’s appointment reflects Apex’s ongoing growth in funding small to mid-sized UK commercial disputes and builds on the company’s commitment to delivering fast, fair, and competitive non-recourse litigation funding solutions to claimant’s who may be prohibited from pursuing meritorious cases due to cost and/or financial risk.

Cartiga’s $540M SPAC with Alchemy

By John Freund |

Cartiga, a long-standing player in consumer and attorney funding, is heading to the public markets. The company agreed to combine with Alchemy Investments Acquisition Corp. 1 in a transaction pegged at $540 million in equity consideration, positioning the platform to scale its data-driven approach to underwriting and portfolio management. Management frames the move as about reach and efficiency: tapping a listed currency, broadening investor access to the asset class, and accelerating inorganic growth.

An article in MarketWatch reports that the proposed business combination would take Cartiga public via Alchemy’s SPAC, with the parties emphasizing how a listing could support growth initiatives and acquisitions. The piece notes the strategic rationale—public-market transparency and capital flexibility—as the platform seeks to deepen its footprint in funding for legal claims and law firms.

While final timing remains subject to customary steps (including the shareholder vote and regulatory filings), the announcement marks one of the most significant U.S. litigation-finance capital-markets events of the year.

Cartiga’s trajectory reflects a broader institutionalization of legal finance: more data, more discipline, and more diversified funding channels. The company’s model—providing non-recourse advances to plaintiffs and working capital to law firms—relies on proprietary analytics and scale to manage risk and returns across cycles. A public listing, if completed, would put Cartiga alongside other listed peers globally and provide investors with another pure-play exposure to the asset class’s uncorrelated return profile.